⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SLDB News
Solid Biosciences Inc. Common Stock
Form 8-K
sec.gov
SLDB
BioGene Therapeutics Inc. Appoints Ty Howton to Board of Directors Ready to Announce with Confidence?
newsfilecorp.com
SRPT
VRTX
SLDB
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SLDB
Solid Biosciences to Participate at Upcoming Investor Conferences
globenewswire.com
SLDB
Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
SLDB
Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy
globenewswire.com
SLDB
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SLDB
Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy
globenewswire.com
SLDB
Global AAV Vector Manufacturing Market Gearing Up for Outstanding Expansion at a CAGR of ~22% by 2034 | DelveInsight
globenewswire.com
PFE
CSL
AMTX
JNJ
SLDB
QURE
TMO
CRL
MRK
TAK
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
globenewswire.com
SLDB